Translate page

Rosti EHA 2019

Current Treatment Approaches in CML
Professor Gianantonio Rosti, University of Bologna, Italy 

  • The natural course of CML
  • A conceptional model for progression for CML
  • The weight of the choice of 1st line treatment:
    2014 vs. 2019
  • Finding the track for 1st line TKI
    • Reaching earlier milestones of response
    • The disease risk
    • Is the patient 'eligible' for treatment discontinuation?
  • Facing a treatment failure
  • Take home messages




This talk was first presented during the Education Session on Chronic Myeloid Leukemia at EHA. You will find more education materials from EHA at the EHA Learning Centre